Two Million CanSino Vaccines Being Packaged in MexicoBy Jorge Ramos Zwanziger | Mon, 03/01/2021 - 18:20
A batch of two million CanSino COVID-19 vaccines that are being packaged in Mexico are set to be administered in the second half of March, according to Forbes Mexico. The vaccines arrived in Mexico on Feb. 11 and are scheduled for packaging at Drugmex’s plant in Queretaro. These are only the first 2 million doses of the 35 million Mexico negotiated with China.
CanSino's vaccine uses a common cold adenovirus to introduce genetic information of SARS-CoV-2 into human cells and create an immune response. Its main advantages are that it requires a single dose and can be stored at 2°C to 8°C. Other vaccines, like Pfizer’s require two doses and storage at -80°C to -60°C. “The data has shown that a single dose can induce a balanced humoral and cellular immune response. In August, it (the CanSino development) became the first patented vaccine to combat COVID-19 in China,” explained CanSino, according to El País. COFEPRIS stated that the vaccines will be packed following international procedures to ensure that each has the appropriate dosage of the active substance while avoiding contamination.
How Is the Country Holding Up Against COVID-19?
The first case of COVID-19 in Mexico was reported last year, on Feb. 28. To date, the country has had over 2 million cases and around 186,000 deaths, according to CSSE COVID-19 Data. On a more positive note, the Mexican government has reported administering 2.46 million doses of COVID-19 vaccines from Pfizer, AstraZeneca, Sinovac and Sputnik V to medics, nurses, hospital staff and adults over 60 all across Mexico, reported El Economista. According to the Ministry of Health, 1.12 million doses have been administered to elders. During the last week of February, around 73,242 doses were administered after the arrival of more Pfizer vaccines, explained the Director-General of Epidemiology, José Luis Alomía Zegarra, according to Proceso. Also, 565,423 people have received the second dose of Pfizer’s vaccine, according to the General Director of the National Center for Preventive Programs and Disease Control (CENAPRECE) of the Ministry of Health, Ruy López Ridaura, reports El Economista. Besides CanSino’s 35 million vaccines, Mexico has agreements to receive 34.4 million doses from Pfizer, 79.4 million from AstraZeneca, 24 million from Sputnik V and 51.4 million from COVAX, according to Forbes Mexico.